Peptide Science Fundamentals
How peptides are built, how they fold, how they signal, and why precise molecular identity is the foundation of every interpretable experiment.
Overview
Peptide science sits between traditional small-molecule chemistry and protein biology. A peptide is a short chain of amino acids linked by peptide bonds. There is no universal length threshold separating peptides from proteins. Chain length, conformation, post-translational modifications, and biological organization all matter. That intermediate position drives both peptides' scientific appeal and the misunderstandings that surround them.
The fundamental unit is the amino acid. Each residue contributes a side chain that can be charged, polar, hydrophobic, or aromatic, and the order of those residues encodes how the molecule presents itself to a receptor or interacting protein. A single substitution can shift binding affinity by orders of magnitude, change selectivity between related receptors, or open a new degradation pathway. Sequence is the most basic identifier of a peptide, but it is rarely sufficient on its own.
Structure adds further specificity. Linear peptides are conformationally flexible. Cyclization, stapling, and disulfide bridges can lock a binding-competent shape and improve protease resistance. Terminal chemistry, including N-terminal acetylation, C-terminal amidation, lipidation, and PEGylation, alters charge, solubility, clearance, and pharmacokinetics. Stereochemistry matters as well: replacing L-amino acids with D-analogues changes both proteolytic stability and target recognition.
Pharmacology depends on these features. Peptides often mimic or modify endogenous signaling molecules, which makes them well suited to receptor agonism, antagonism, and disruption of protein-protein interactions. They can present larger interaction surfaces than small molecules and recognize sites that are difficult to address with conventional chemistry. The tradeoff is exposure: native peptides are typically cleared rapidly, are vulnerable to proteases, and have limited oral bioavailability. Engineered analogues such as albumin binders, lipidated peptides, and DAC conjugates exist precisely to manage that tradeoff.
This hub collects foundational articles that build that vocabulary. The goal is not to recommend any compound or claim therapeutic effect; it is to equip researchers to read primary literature, evaluate documentation, and distinguish a defined molecular entity from a marketplace label.